3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with phenserine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greig, NH; Ingram, DK; Meyer, RC; Patel, N; Spangler, EL; Yu, QS | 1 |
1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and phenserine
Article | Year |
---|---|
Phenserine, a novel acetylcholinesterase inhibitor, attenuates impaired learning of rats in a 14-unit T-maze induced by blockade of the N-methyl-D-aspartate receptor.
Topics: Animals; Cholinesterase Inhibitors; Excitatory Amino Acid Antagonists; Learning Disabilities; Male; Maze Learning; Physostigmine; Piperazines; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate | 1998 |